Sponsors Should Disclose Trial Data Even During Development, JAMA Says
Executive Summary
Product sponsors need to publicly disclose more data about their products while they are in development in order to protect patients from unnecessary risk, authors of a study published April 28 in the Journal of the American Medical Association posit
You may also be interested in...
Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role
FDA's appointment of a high-profile consumer advocate to an Office of the Commissioner post continues a strategy of bringing some of the most outspoken critics of both the drug industry and its regulatory agency into FDA
Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role
FDA's appointment of consumer advocate Peter Lurie to an Office of the Commissioner policy post suggests a strategy of bringing in some of the most outspoken critics of both the drug industry and FDA to address public perceptions of the agency
Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role
FDA's appointment of a high-profile consumer advocate to an Office of the Commissioner post continues a strategy of bringing some of the most outspoken critics of both the drug industry and its regulatory agency into FDA